<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-04-26" modified="2017-10-25" version="160">
<accession>O43255</accession>
<accession>O43270</accession>
<name>SIAH2_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase SIAH2</fullName>
<ecNumber>2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="16">RING-type E3 ubiquitin transferase SIAH2</fullName>
</alternativeName>
<alternativeName>
<fullName>Seven in absentia homolog 2</fullName>
<shortName>Siah-2</shortName>
<shortName>hSiah2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SIAH2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Genomics" volume="46" first="103" last="111">
<title>Characterization of human homologs of the Drosophila seven in absentia (sina) gene.</title>
<authorList>
<person name="Hu G."/>
<person name="Chung Y.-L."/>
<person name="Glover T."/>
<person name="Valentine V."/>
<person name="Look A.T."/>
<person name="Fearon E.R."/>
</authorList>
<dbReference type="PubMed" id="9403064"/>
<dbReference type="DOI" id="10.1006/geno.1997.4997"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="3798" last="3807">
<title>hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.</title>
<authorList>
<person name="Germani A."/>
<person name="Romero F."/>
<person name="Houlard M."/>
<person name="Camonis J."/>
<person name="Gisselbrecht S."/>
<person name="Fischer S."/>
<person name="Varin-Blank N."/>
</authorList>
<dbReference type="PubMed" id="10207103"/>
<dbReference type="DOI" id="10.1128/MCB.19.5.3798"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>INTERACTION WITH VAV1</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Genes Dev." volume="11" first="2701" last="2714">
<title>Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome pathway.</title>
<authorList>
<person name="Hu G."/>
<person name="Zhang S."/>
<person name="Vidal M."/>
<person name="Baer J.L."/>
<person name="Xu T."/>
<person name="Fearon E.R."/>
</authorList>
<dbReference type="PubMed" id="9334332"/>
<dbReference type="DOI" id="10.1101/gad.11.20.2701"/>
</citation>
<scope>FUNCTION IN DEGRADATION OF DCC</scope>
<scope>INTERACTION WITH UBE2I</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="4153" last="4162">
<title>Regulation of BOB.1/OBF.1 stability by SIAH.</title>
<authorList>
<person name="Boehm J."/>
<person name="He Y."/>
<person name="Greiner A."/>
<person name="Staudt L."/>
<person name="Wirth T."/>
</authorList>
<dbReference type="PubMed" id="11483518"/>
<dbReference type="DOI" id="10.1093/emboj/20.15.4153"/>
</citation>
<scope>FUNCTION IN DEGRADATION OF POU2AF1</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="915" last="926">
<title>Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.</title>
<authorList>
<person name="Matsuzawa S."/>
<person name="Reed J.C."/>
</authorList>
<dbReference type="PubMed" id="11389839"/>
<dbReference type="DOI" id="10.1016/S1097-2765(01)00242-8"/>
</citation>
<scope>INTERACTION WITH CACYBP</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="5756" last="5765">
<title>Stress-induced decrease in TRAF2 stability is mediated by Siah2.</title>
<authorList>
<person name="Habelhah H."/>
<person name="Frew I.J."/>
<person name="Laine A."/>
<person name="Janes P.W."/>
<person name="Relaix F."/>
<person name="Sassoon D."/>
<person name="Bowtell D.D.L."/>
<person name="Ronai Z."/>
</authorList>
<dbReference type="PubMed" id="12411493"/>
<dbReference type="DOI" id="10.1093/emboj/cdf576"/>
</citation>
<scope>FUNCTION IN DEGRADATION OF TRAF2</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="3043" last="3048">
<title>Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1.</title>
<authorList>
<person name="Okabe H."/>
<person name="Satoh S."/>
<person name="Furukawa Y."/>
<person name="Kato T."/>
<person name="Hasegawa S."/>
<person name="Nakajima Y."/>
<person name="Yamaoka Y."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="12810624"/>
</citation>
<scope>INTERACTION WITH PEG10</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Biochem. J." volume="397" first="179" last="186">
<title>Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.</title>
<authorList>
<person name="Tian Y.M."/>
<person name="Mole D.R."/>
<person name="Ratcliffe P.J."/>
<person name="Gleadle J.M."/>
</authorList>
<dbReference type="PubMed" id="16509823"/>
<dbReference type="DOI" id="10.1042/BJ20051996"/>
</citation>
<scope>INTERACTION WITH EGLN2</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="11706" last="11716">
<title>Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.</title>
<authorList>
<person name="Szargel R."/>
<person name="Rott R."/>
<person name="Eyal A."/>
<person name="Haskin J."/>
<person name="Shani V."/>
<person name="Balan L."/>
<person name="Wolosker H."/>
<person name="Engelender S."/>
</authorList>
<dbReference type="PubMed" id="19224863"/>
<dbReference type="DOI" id="10.1074/jbc.M805990200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SNCAIP</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2012" name="J. Mol. Cell Biol." volume="4" first="316" last="330">
<title>Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways.</title>
<authorList>
<person name="Perez M."/>
<person name="Garcia-Limones C."/>
<person name="Zapico I."/>
<person name="Marina A."/>
<person name="Schmitz M.L."/>
<person name="Munoz E."/>
<person name="Calzado M.A."/>
</authorList>
<dbReference type="PubMed" id="22878263"/>
<dbReference type="DOI" id="10.1093/jmcb/mjs047"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DYRK2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-16; THR-26; SER-28; SER-68 AND THR-119</scope>
<scope>MUTAGENESIS OF SER-16; THR-26; SER-28; SER-68 AND THR-119</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<comment type="function">
<text evidence="8 9 12 13 14">E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of target proteins. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Mediates E3 ubiquitin ligase activity either through direct binding to substrates or by functioning as the essential RING domain subunit of larger E3 complexes. Triggers the ubiquitin-mediated degradation of many substrates, including proteins involved in transcription regulation (POU2AF1, PML, NCOR1), a cell surface receptor (DCC), an antiapoptotic protein (BAG1), and a protein involved in synaptic vesicle function in neurons (SYP). Mediates ubiquitination and proteasomal degradation of DYRK2 in response to hypoxia. It is thereby involved in apoptosis, tumor suppression, cell cycle, transcription and signaling processes. Has some overlapping function with SIAH1. Triggers the ubiquitin-mediated degradation of TRAF2, whereas SIAH1 does not. Promotes monoubiquitination of SNCA.</text>
</comment>
<comment type="catalytic activity">
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="12">Inhibited by interaction with SNCAIP (isoform 2, but not isoform 1). May be inhibited by interaction with PEG10.</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="3 6 7 10 11 12 13 14">Homodimer. Interacts with UBE2E2. Interacts with PEG3 (By similarity). Interacts with VAV1, without mediating its ubiquitin-mediated degradation. Interacts with CACYBP/SIP. Probable component of some large E3 complex possibly composed of UBE2D1, SIAH2, CACYBP/SIP, SKP1, APC and TBL1X. Interacts with PEG10, which may inhibit its activity. Interacts with EGLN2 and SNCAIP. Interacts with DYRK2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948141"/>
<interactant intactId="EBI-444209">
<id>O95835</id>
<label>LATS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948141"/>
<interactant intactId="EBI-3506895">
<id>Q9NRM7</id>
<label>LATS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948141"/>
<interactant intactId="EBI-2624570">
<id>P35372</id>
<label>OPRM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948141"/>
<interactant intactId="EBI-311339">
<id>Q7Z6J0</id>
<label>SH3RF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Predominantly cytoplasmic. Partially nuclear.</text>
</comment>
<comment type="tissue specificity">
<text evidence="15">Widely expressed at low level.</text>
</comment>
<comment type="domain">
<text>The RING-type zinc finger domain is essential for ubiquitin ligase activity.</text>
</comment>
<comment type="domain">
<text evidence="3">The SBD domain (substrate-binding domain) mediates the homodimerization and the interaction with substrate proteins. It is related to the TRAF family.</text>
</comment>
<comment type="PTM">
<text evidence="3 13">Phosphorylated at Ser-28 by MAPK14, which mediates the degradation by the proteasome of EGLN3 (By similarity). Phosphorylated at Ser-28 by DYRK2; this increases the ubiquitin ligase activity and promotes degradation of EGLN3.</text>
</comment>
<comment type="similarity">
<text evidence="16">Belongs to the SINA (Seven in absentia) family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/SIAH2ID46199ch3q25.html"/>
</comment>
<dbReference type="EC" id="2.3.2.27"/>
<dbReference type="EMBL" id="U76248">
<property type="protein sequence ID" value="AAC51908.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y15268">
<property type="protein sequence ID" value="CAA75557.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC013082">
<property type="protein sequence ID" value="AAH13082.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3152.1"/>
<dbReference type="RefSeq" id="NP_005058.3">
<property type="nucleotide sequence ID" value="NM_005067.5"/>
</dbReference>
<dbReference type="UniGene" id="Hs.477959"/>
<dbReference type="UniGene" id="Hs.692394"/>
<dbReference type="PDB" id="5H9M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="A/B=131-321"/>
</dbReference>
<dbReference type="PDBsum" id="5H9M"/>
<dbReference type="ProteinModelPortal" id="O43255"/>
<dbReference type="SMR" id="O43255"/>
<dbReference type="BioGrid" id="112373">
<property type="interactions" value="70"/>
</dbReference>
<dbReference type="DIP" id="DIP-41874N"/>
<dbReference type="IntAct" id="O43255">
<property type="interactions" value="22"/>
</dbReference>
<dbReference type="MINT" id="MINT-200601"/>
<dbReference type="STRING" id="9606.ENSP00000322457"/>
<dbReference type="iPTMnet" id="O43255"/>
<dbReference type="PhosphoSitePlus" id="O43255"/>
<dbReference type="BioMuta" id="SIAH2"/>
<dbReference type="MaxQB" id="O43255"/>
<dbReference type="PaxDb" id="O43255"/>
<dbReference type="PeptideAtlas" id="O43255"/>
<dbReference type="PRIDE" id="O43255"/>
<dbReference type="Ensembl" id="ENST00000312960">
<property type="protein sequence ID" value="ENSP00000322457"/>
<property type="gene ID" value="ENSG00000181788"/>
</dbReference>
<dbReference type="GeneID" id="6478"/>
<dbReference type="KEGG" id="hsa:6478"/>
<dbReference type="UCSC" id="uc003eyi.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6478"/>
<dbReference type="DisGeNET" id="6478"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000181788.3"/>
<dbReference type="GeneCards" id="SIAH2"/>
<dbReference type="H-InvDB" id="HIX0163461"/>
<dbReference type="HGNC" id="HGNC:10858">
<property type="gene designation" value="SIAH2"/>
</dbReference>
<dbReference type="HPA" id="CAB069930"/>
<dbReference type="HPA" id="HPA061293"/>
<dbReference type="MIM" id="602213">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O43255"/>
<dbReference type="OpenTargets" id="ENSG00000181788"/>
<dbReference type="PharmGKB" id="PA35760"/>
<dbReference type="eggNOG" id="KOG3002">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XVP0">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000005434"/>
<dbReference type="HOGENOM" id="HOG000231487"/>
<dbReference type="HOVERGEN" id="HBG055701"/>
<dbReference type="InParanoid" id="O43255"/>
<dbReference type="KO" id="K08742"/>
<dbReference type="OMA" id="IDPPQNE"/>
<dbReference type="OrthoDB" id="EOG091G0BPY"/>
<dbReference type="PhylomeDB" id="O43255"/>
<dbReference type="TreeFam" id="TF312976"/>
<dbReference type="Reactome" id="R-HSA-373752">
<property type="pathway name" value="Netrin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977225">
<property type="pathway name" value="Amyloid fiber formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983168">
<property type="pathway name" value="Antigen processing: Ubiquitination &amp; Proteasome degradation"/>
</dbReference>
<dbReference type="SIGNOR" id="O43255"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="ChiTaRS" id="SIAH2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SIAH2"/>
<dbReference type="GenomeRNAi" id="6478"/>
<dbReference type="PRO" id="PR:O43255"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000181788"/>
<dbReference type="CleanEx" id="HS_SIAH2"/>
<dbReference type="ExpressionAtlas" id="O43255">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O43255">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0031624">
<property type="term" value="F:ubiquitin conjugating enzyme binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0044257">
<property type="term" value="P:cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090090">
<property type="term" value="P:negative regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043154">
<property type="term" value="P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001237">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031396">
<property type="term" value="P:regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007264">
<property type="term" value="P:small GTPase mediated signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.210.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR018121">
<property type="entry name" value="7-in-absentia-prot_TRAF-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR004162">
<property type="entry name" value="SINA-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR008974">
<property type="entry name" value="TRAF-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR013010">
<property type="entry name" value="Znf_SIAH"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10315">
<property type="entry name" value="PTHR10315"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03145">
<property type="entry name" value="Sina"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49599">
<property type="entry name" value="SSF49599"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51081">
<property type="entry name" value="ZF_SIAH"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="E3 ubiquitin-protein ligase SIAH2" id="PRO_0000056168">
<location>
<begin position="1"/>
<end position="324"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="4">
<location>
<begin position="80"/>
<end position="115"/>
</location>
</feature>
<feature type="zinc finger region" description="SIAH-type" evidence="5">
<location>
<begin position="133"/>
<end position="193"/>
</location>
</feature>
<feature type="region of interest" description="SBD">
<location>
<begin position="130"/>
<end position="322"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="3">
<location>
<position position="138"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="3">
<location>
<position position="145"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="3">
<location>
<position position="157"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="3">
<location>
<position position="161"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="3">
<location>
<position position="168"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="3">
<location>
<position position="175"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="3">
<location>
<position position="187"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="3">
<location>
<position position="192"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DYRK2" evidence="13">
<location>
<position position="16"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by DYRK2" evidence="13">
<location>
<position position="26"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DYRK2 and MAPK14" evidence="13">
<location>
<position position="28"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DYRK2" evidence="13">
<location>
<position position="68"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by DYRK2" evidence="13">
<location>
<position position="119"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation by DYRK2; when associated with A-26; A-28; A-68 and A-119." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation by DYRK2; when associated with A-16; A-28; A-68 and A-119." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation by DYRK2; when associated with A-16; A-26; A-68 and A-119." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation by DYRK2; when associated with A-16; A-26; A-28 and A-119." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation by DYRK2; when associated with A-16; A-26; A-28 and A-68." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC51908." ref="1" evidence="16">
<original>G</original>
<variation>E</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="151"/>
<end position="153"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="154"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="184"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="196"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="217"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="227"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="242"/>
<end position="253"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="255"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="262"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="272"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="288"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="296"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="301"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="312"/>
<end position="320"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5H9M"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00455"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10207103"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389839"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11483518"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12411493"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12810624"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16509823"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19224863"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22878263"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9334332"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9403064"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000305"/>
<sequence length="324" mass="34615" checksum="2D5DD845666EC924" modified="1998-06-01" version="1">
MSRPSSTGPSANKPCSKQPPPQPQHTPSPAAPPAAATISAAGPGSSAVPAAAAVISGPGG
GGGAGPVSPQHHELTSLFECPVCFDYVLPPILQCQAGHLVCNQCRQKLSCCPTCRGALTP
SIRNLAMEKVASAVLFPCKYATTGCSLTLHHTEKPEHEDICEYRPYSCPCPGASCKWQGS
LEAVMSHLMHAHKSITTLQGEDIVFLATDINLPGAVDWVMMQSCFGHHFMLVLEKQEKYE
GHQQFFAIVLLIGTRKQAENFAYRLELNGNRRRLTWEATPRSIHDGVAAAIMNSDCLVFD
TAIAHLFADNGNLGINVTISTCCP
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>